Debrisoquine 4-Hydroxylase: Characterization of a New P450 Gene Subfamily, Regulation, Chromosomal Mapping, and Molecular Analysis of the DA Rat Polymorphism-Reference-Cited by-同舟云学术

Debrisoquine 4-Hydroxylase: Characterization of a New P450 Gene Subfamily, Regulation, Chromosomal Mapping, and Molecular Analysis of the DA Rat Polymorphism

Published:1987-04 Issue:2 Volume:6 Page:149-161
ISSN:0198-0238
Container-title:DNA
language:en
Short-container-title:DNA

Author:

GONZALEZ FRANK J.,MATSUNAGA TAMIHIDE,NAGATA KIYOSHI,MEYER URS A.,NEBERT DANIEL W.,PASTEWKA JULLIA,KOZAK CHRISTINE A.,GILLETTE JAMES,GELBOIN HARRY V.,HARDWICK JAMES P.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Biochemistry

Link

http://www.liebertpub.com/doi/pdf/10.1089/dna.1987.6.149

Reference32 articles.

1. Animal modelling of human polymorphic drug oxidation—the metabolism of debrisoquine and phenacetin in rat inbred strains

2. Gene conversion in a cytochrome P-450 gene family.

3. Bufuralol 1'-hydroxylase activity of the rat

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential impact of CYP and UGT drug-metabolizing enzymes on brain target site drug exposure;Drug Metabolism Reviews;2023-12-21

2. Impact of physiological, pathological and environmental factors on the expression and activity of human cytochrome P450 2D6 and implications in precision medicine;Drug Metabolism Reviews;2015-10-02

3. Sex hormones regulate cerebral drug metabolism via brain miRNAs: down-regulation of brain CYP2D by androgens reduces the analgesic effects of tramadol;British Journal of Pharmacology;2015-08-26

4. Polymorphisms of CYP2D17 in Cynomolgus and Rhesus Macaques: an Evidence of the Genetic Basis for the Variability of CYP2D-Dependent Drug Metabolism;Drug Metabolism and Disposition;2014-07-01

5. Interindividual Variations in Metabolism and Pharmacokinetics of 3-(6-Methylpyridine-3-yl-sulfanyl)-6-(4H-[1,2,4]triazole-3-yl-sulfanyl)-N-(1,3-thiazole-2-yl)-2-pyridine carboxamide, a Glucokinase Activator, in Rats Caused by the Genetic Polymorphism of CYP2D1;Drug Metabolism and Disposition;2014-06-12